Indication

Cardiogenic shock

Cardiogenic shock is a critical, life-threatening cardiovascular syndrome characterized by primary cardiac pump failure that leads to severely reduced cardiac output, systemic hypoperfusion, and widespread tissue hypoxia despite adequate intravascular volume. Read more about Cardiogenic shock

20 drugs 9 manufacturers

Advertisement

Drugs that treat it

Common Cardiogenic shock therapies.

Showing 1–9 of 20 drugs

Filter & compare in the drug finder →Opens the drug finder with Cardiogenic shock preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Cardiogenic shock.

Cardiogenic shock is a critical, life-threatening cardiovascular syndrome characterized by primary cardiac pump failure that leads to severely reduced cardiac output, systemic hypoperfusion, and widespread tissue hypoxia despite adequate intravascular volume.

Most commonly triggered by acute myocardial infarction, it can also stem from severe cardiomyopathies, valvular disruption, mechanical complications, or intractable arrhythmias.

Pathophysiologically, sustained myocardial dysfunction initiates a vicious cycle of persistent hypotension, increased ventricular filling pressures, systemic vasoconstriction, and impaired coronary perfusion.

Clinically, it manifests as profound arterial hypotension, altered mental status, cold extremities, oliguria, elevated serum lactate, and progressive multiorgan dysfunction.

Personalize your experience

Follow Cardiogenic shock and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it